Top Markets
Coin of the day
AroCell AB (publ) AroCell AB (publ)

AroCell AB (publ)

AROC
Rang in aandelen #31792
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Aandeelprijs
$0.05234265
Laatst gesynchroniseerd: 2025-06-23
Marktkapitalisatie
$12.06M
Verandering (1 dag)
-3.01%
Verandering (1 jaar)
0.00%
Land
SE
Handel AroCell AB (publ) (AROC)

Categorie

Dividendrendementgeschiedenis voor AroCell AB (publ) (AROC)
Het dividendrendement (TTM) van AroCell AB (publ) (aandelsymbool: AROC) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van AroCell AB (publ) (AROC) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten